Adage Capital Partners’s DICE Therapeutics DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-30,000
Closed -$574K – 1165
2022
Q1
$574K Sell
30,000
-220,000
-88% -$3.93M ﹤0.01% 950
2021
Q4
$6.33M Hold
250,000
– – 0.01% 790
2021
Q3
$8.19M Buy
+250,000
New +$8.51M 0.02% 753

Other funds holding DICE

Adage Capital Partners's DICE Position: Q2 2022 in Review

Adage Capital Partners sold out of DICE Therapeutics (DICE) in Q2 2022, closing a stake of 30,000 shares — an estimated $574K sold.

Adage Capital Partners first reported a position in DICE in Q3 2021 and held it in 3 quarters. The position peaked at $8.19M in Q3 2021. 80 funds tracked by Wall St. Rank hold DICE as of Q2 2022.

  • Adage Capital Partners reported no remaining DICE Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Adage Capital Partners sold 30,000 DICE Therapeutics shares in Q2 2022, an estimated $574K.
  • Adage Capital Partners first reported a position in DICE Therapeutics in Q3 2021 and held it in 3 quarters.
  • Adage Capital Partners's DICE Therapeutics position peaked at $8.19M in Q3 2021.
  • 80 funds tracked by Wall St. Rank held DICE Therapeutics as of Q2 2022.

Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.